Printer Friendly

OXFORD MOLECULAR, INTERNATIONAL BIOTECHNOLOGY SOFTWARE COMPANY, ESTABLISHES U.S. OPERATIONS

 OXFORD MOLECULAR, INTERNATIONAL BIOTECHNOLOGY SOFTWARE COMPANY,
 ESTABLISHES U.S. OPERATIONS
 PALO ALTO, Calif., July 1 /PRNewswire/ -- Oxford Molecular, an international biotechnology software company, established its first U.S. office in Palo Alto. The company currently has offices in Paris, France, and Tokyo, Japan, with headquarters at the Oxford Science Park in the United Kingdom.
 Oxford Molecular was founded in 1989, to commercialize state-of-the- art academic software originally developed in the research laboratories at Oxford University. The company has broadened its base and now enhances and publishes software from other premier academic institutions. This business strategy gives Oxford Molecular a number of advantages over its competitors. First, the company's close links with academia means that they can be first to the commercial marketplace with new academic developments. Second, as a publisher, development costs are reduced, allowing the company to provide industrial customers with software at very attractive prices. The company pays the academic authors' royalties, and nurtures new relationships with academia by offering a low cost site license to universities.
 The product line includes a number of unique, innovative products for the computational chemistry and protein modeling markets. The product line includes the work of respected academics: Professor Tony Rees, University of Bath, Professor Janet Thornton, University College, London and Dr. Graham Richards, University of Oxford.
 Heading up North American marketing activities is Dr. Stefan Unger, vice president of marketing for Oxford Molecular Inc. Unger was formerly manager of Chemistry and Biotechnology Applications at Silicon Graphics Inc., and prior to that spent 16 years at Syntex as head of Computer Aided Drug Design. "Unger's role will be to develop the U.S. market and to identify U.S. academic sources for new products," said Dr. Tony Marchington, managing director of Oxford Molecular Ltd. Strategic Relationships
 The company has established strategic academic collaborations with the following institutions:
 -- University College, London -- University of Bath
 -- University of Oxford -- University of Leeds
 -- University of Arizona
 -- National Institute of Medical Research The company has also established strategic business relationships with:
 -- Glaxo Group Research -- British Bio-technology
 -- SmithKline Beecham -- Pfizer
 -- Hewlett-Packard -- Apple Computer
 -- Silicon Graphics -- Toray Systems (Japan)
 -0- 7/1/92
 /CONTACT: Stefan Unger of Oxford Molecular, 415-494-6274/ CO: Oxford Molecular Inc. ST: California IN: MTC SU:


MM-MC -- SJ003 -- 5731 07/01/92 13:00 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jul 1, 1992
Words:379
Previous Article:DATA SWITCH ANNOUNCES PROMOTIONS, EXPANDED MANAGEMENT ROLES
Next Article:UNOCAL ANNOUNCES WILDCAT NATURAL GAS DISCOVERY
Topics:


Related Articles
OXFORD MOLECULAR ACQUIRES INTELLIGENETICS, INC.
OXFORD MOLECULAR GROUP PLC ACQUIRES CACHE SCIENTIFIC INC.
OXFORD MOLECULAR GROUP PLC ACQUIRES CACHE SCIENTIFIC INC.
OXFORD MOLECULAR, UNIVERSITY OF CALIFORNIA SAN FRANCISCO FORM CO-DISTRIBUTION PARTNERSHIP FOR AMBER
OXFORD MOLECULAR GROUP, PLC PROPOSED ACQUISITIONS
OXFORD MOLECULAR GROUP COMPLETES UNICHEM SOFTWARE AND TECHNOLOGY ACQUISITION FROM CRAY RESEARCH, INC.
Oxford Molecular to Distribute CS ChemOffice Software in Europe
Oxford Molecular Group Delivers MacVector 6.0
First Product Results From Oxford Molecular and Glaxo Wellcome Collaboration
Oxford Molecular and Genetics Computer Group Connect; Creation of New Client/Server Solutions for Bioinformatics

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters